Nothing Special   »   [go: up one dir, main page]

SE0101387D0 - Novel compounds - Google Patents

Novel compounds

Info

Publication number
SE0101387D0
SE0101387D0 SE0101387A SE0101387A SE0101387D0 SE 0101387 D0 SE0101387 D0 SE 0101387D0 SE 0101387 A SE0101387 A SE 0101387A SE 0101387 A SE0101387 A SE 0101387A SE 0101387 D0 SE0101387 D0 SE 0101387D0
Authority
SE
Sweden
Prior art keywords
novel compounds
compounds
pain
therapy
salts
Prior art date
Application number
SE0101387A
Other languages
English (en)
Inventor
Yun-Xing Cheng
Miroslaw J Tomaszewski
Christopher Walpole
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Priority to SE0101387A priority Critical patent/SE0101387D0/sv
Publication of SE0101387D0 publication Critical patent/SE0101387D0/sv
Priority to SK1303-2003A priority patent/SK13032003A3/sk
Priority to MYPI20021423A priority patent/MY134568A/en
Priority to NZ528403A priority patent/NZ528403A/en
Priority to EP02764120A priority patent/EP1390350A1/en
Priority to UA2003108942A priority patent/UA76743C2/uk
Priority to CNB028085779A priority patent/CN1250531C/zh
Priority to BR0208907-6A priority patent/BR0208907A/pt
Priority to MXPA03009558A priority patent/MXPA03009558A/es
Priority to CA002444381A priority patent/CA2444381A1/en
Priority to EEP200300524A priority patent/EE200300524A/xx
Priority to JP2002583393A priority patent/JP2004528334A/ja
Priority to US10/474,549 priority patent/US7030139B2/en
Priority to KR10-2003-7013622A priority patent/KR20040022421A/ko
Priority to NZ538692A priority patent/NZ538692A/en
Priority to IL15814202A priority patent/IL158142A0/xx
Priority to CZ20032833A priority patent/CZ20032833A3/cs
Priority to HU0303825A priority patent/HUP0303825A3/hu
Priority to PL02366517A priority patent/PL366517A1/xx
Priority to RU2003129638/04A priority patent/RU2312864C2/ru
Priority to PCT/SE2002/000769 priority patent/WO2002085866A1/en
Priority to ARP020101441A priority patent/AR035959A1/es
Priority to IS6971A priority patent/IS6971A/is
Priority to ZA200307752A priority patent/ZA200307752B/en
Priority to BG108271A priority patent/BG108271A/bg
Priority to NO20034665A priority patent/NO20034665L/no
Priority to US11/325,124 priority patent/US20060135554A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C07D235/12—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/30—Nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyridine Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SE0101387A 2001-04-20 2001-04-20 Novel compounds SE0101387D0 (sv)

Priority Applications (27)

Application Number Priority Date Filing Date Title
SE0101387A SE0101387D0 (sv) 2001-04-20 2001-04-20 Novel compounds
PCT/SE2002/000769 WO2002085866A1 (en) 2001-04-20 2002-04-18 Novel compounds
US10/474,549 US7030139B2 (en) 2001-04-20 2002-04-18 Compounds
NZ538692A NZ538692A (en) 2001-04-20 2002-04-18 Chemical process involving selective reduction of a nitro moiety
NZ528403A NZ528403A (en) 2001-04-20 2002-04-18 CB2 receptor agonists
EP02764120A EP1390350A1 (en) 2001-04-20 2002-04-18 Novel compounds
UA2003108942A UA76743C2 (uk) 2001-04-20 2002-04-18 Похідні конденсованого імідазолу, фармацевтична композиція на їх основі
CNB028085779A CN1250531C (zh) 2001-04-20 2002-04-18 新化合物
BR0208907-6A BR0208907A (pt) 2001-04-20 2002-04-18 Composto uso de um composto, composição farmacêutica, métodos para a terapia da dor em um animal de sangue quente e para a redução seletiva de uma porção nitro orto para um substituinte amino em um anel fenila ou piridila de um composto.
MXPA03009558A MXPA03009558A (es) 2001-04-20 2002-04-18 Compuestos novedosos.
CA002444381A CA2444381A1 (en) 2001-04-20 2002-04-18 Novel compounds
EEP200300524A EE200300524A (et) 2001-04-20 2002-04-18 Ühendid, mis on CB2-retseptori agonistid, neid sisaldavad ravimkoostised ja nimetatud ühendite kasutamine ravis
JP2002583393A JP2004528334A (ja) 2001-04-20 2002-04-18 新規な化合物
SK1303-2003A SK13032003A3 (sk) 2001-04-20 2002-04-18 Zlúčeniny a ich soli, ktoré sú agonistami receptora CB2, farmaceutické kompozície s ich obsahom a ich použitie v terapii
KR10-2003-7013622A KR20040022421A (ko) 2001-04-20 2002-04-18 신규 화합물
MYPI20021423A MY134568A (en) 2001-04-20 2002-04-18 Cb2 receptor agonists
IL15814202A IL158142A0 (en) 2001-04-20 2002-04-18 Novel compounds
CZ20032833A CZ20032833A3 (en) 2001-04-20 2002-04-18 Novel compounds
HU0303825A HUP0303825A3 (en) 2001-04-20 2002-04-18 1h-benzimidazole and 3h-imidazo-[4,5b]pyridine-derivatives, their use and pharmaceutical compositions containing them
PL02366517A PL366517A1 (en) 2001-04-20 2002-04-18 Novel compounds
RU2003129638/04A RU2312864C2 (ru) 2001-04-20 2002-04-18 Новые соединения конденсированного имидазола, обладающие свойствами агонистов рецептора св2
ARP020101441A AR035959A1 (es) 2001-04-20 2002-04-19 Compuestos agonistas en el receptor cb2, uso de estos compuestos para la manufactura de un medicamento para utilizar en la terapia del dolor, composicion farmaceutica, y metodo de reduccion
IS6971A IS6971A (is) 2001-04-20 2003-09-29 Ný efnasambönd
ZA200307752A ZA200307752B (en) 2001-04-20 2003-10-03 Novel compounds.
BG108271A BG108271A (bg) 2001-04-20 2003-10-14 Нови съединения
NO20034665A NO20034665L (no) 2001-04-20 2003-10-17 Nye forbindelser
US11/325,124 US20060135554A1 (en) 2001-04-20 2006-01-04 Novel compounds

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0101387A SE0101387D0 (sv) 2001-04-20 2001-04-20 Novel compounds

Publications (1)

Publication Number Publication Date
SE0101387D0 true SE0101387D0 (sv) 2001-04-20

Family

ID=20283822

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0101387A SE0101387D0 (sv) 2001-04-20 2001-04-20 Novel compounds

Country Status (25)

Country Link
US (2) US7030139B2 (sv)
EP (1) EP1390350A1 (sv)
JP (1) JP2004528334A (sv)
KR (1) KR20040022421A (sv)
CN (1) CN1250531C (sv)
AR (1) AR035959A1 (sv)
BG (1) BG108271A (sv)
BR (1) BR0208907A (sv)
CA (1) CA2444381A1 (sv)
CZ (1) CZ20032833A3 (sv)
EE (1) EE200300524A (sv)
HU (1) HUP0303825A3 (sv)
IL (1) IL158142A0 (sv)
IS (1) IS6971A (sv)
MX (1) MXPA03009558A (sv)
MY (1) MY134568A (sv)
NO (1) NO20034665L (sv)
NZ (1) NZ528403A (sv)
PL (1) PL366517A1 (sv)
RU (1) RU2312864C2 (sv)
SE (1) SE0101387D0 (sv)
SK (1) SK13032003A3 (sv)
UA (1) UA76743C2 (sv)
WO (1) WO2002085866A1 (sv)
ZA (1) ZA200307752B (sv)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE0203070D0 (en) * 2002-10-16 2002-10-16 Astrazeneca Ab Novel compounds
KR20050122210A (ko) * 2003-03-17 2005-12-28 다케다 샌디에고, 인코포레이티드 히스톤 탈아세틸화 효소 억제제
SE0300908D0 (sv) * 2003-03-31 2003-03-31 Astrazeneca Ab Azaindole derivatives, preparations thereof, uses thereof and compositions containing them
SE0301446D0 (sv) * 2003-05-16 2003-05-16 Astrazeneca Ab New Compounds
SE0301699D0 (sv) * 2003-06-10 2003-06-10 Astrazeneca Ab Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
SE0301701D0 (sv) * 2003-06-10 2003-06-10 Astrazeneca Ab Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
SE0301698D0 (sv) * 2003-06-10 2003-06-10 Astrazeneca Ab Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
US7465815B2 (en) * 2003-06-26 2008-12-16 Takeda Pharmaceutical Company Limited Cannabinoid receptor modulator
US7157471B2 (en) * 2003-08-25 2007-01-02 Boehringer Ingelheim International Gmbh Haloalkyl- and piperidine-substituted benzimidazole-derivatives
WO2005021547A2 (en) * 2003-08-28 2005-03-10 Pharmaxis Pty Ltd. Heterocyclic cannabinoid cb2 receptor antagonists
SE0302570D0 (sv) * 2003-09-26 2003-09-26 Astrazeneca Ab Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
SE0302571D0 (sv) * 2003-09-26 2003-09-26 Astrazeneca Ab Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
SE0302573D0 (sv) * 2003-09-26 2003-09-26 Astrazeneca Ab Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
SE0302572D0 (sv) * 2003-09-26 2003-09-26 Astrazeneca Ab Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
JP2007509072A (ja) 2003-10-16 2007-04-12 キャラ セラピューティックス， インコーポレイテッド アミドまたはチオアミド誘導体および疼痛の処置におけるその使用方法
EP1797070A1 (en) * 2004-09-24 2007-06-20 AstraZeneca AB Compounds, compositions containing them, preparations thereof and uses thereof ii
CA2582507A1 (en) * 2004-09-24 2006-03-30 Astrazeneca Ab Compounds, compositions containing them, preparation thereof and uses thereof iii
CN101052639B (zh) * 2004-09-24 2010-10-27 阿斯利康(瑞典)有限公司 苯并咪唑衍生物、含有它们的组合物、其制备方法和其用途
JP2008514591A (ja) * 2004-09-24 2008-05-08 アストラゼネカ・アクチエボラーグ ベンゾイミダゾール誘導体及びカンナビノイド受容体リガンドとしてのその使用
JP2008514590A (ja) * 2004-09-24 2008-05-08 アストラゼネカ・アクチエボラーグ ベンゾイミダゾール誘導体、それを含む組成物、その製造方法及びその使用
WO2006033627A1 (en) * 2004-09-24 2006-03-30 Astrazeneca Ab Compounds, compositions containing them, preparation thereof and uses thereof iiii
EP1794150A1 (en) * 2004-09-24 2007-06-13 AstraZeneca AB Benzimidazole derivatives and their use as cannabinoid receptor ligands I
CA2581232C (en) * 2004-09-24 2015-04-07 Astrazeneca Ab Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof i
KR101269869B1 (ko) * 2004-09-24 2013-06-07 네오메드 인스티튜트 벤즈이미다졸 유도체, 그를 함유하는 조성물, 그의 제조방법 및 그의 용도
JP2008517959A (ja) 2004-10-27 2008-05-29 エフ．ホフマン−ラ ロシュ アーゲー 新規なインドール又はベンゾイミダゾール誘導体
BRPI0517925A (pt) 2004-11-02 2008-10-21 Pfizer derivados de sulfonil benzimidazol
SE0402763D0 (sv) * 2004-11-11 2004-11-11 Astrazeneca Ab Nitro indazole derivatives
SE0402762D0 (sv) * 2004-11-11 2004-11-11 Astrazeneca Ab Indazole sulphonamide derivatives
CA2601458C (en) * 2005-03-15 2011-04-26 Pfizer Inc. Benzimidazolone derivatives as cb2 receptor ligands
CA2602368A1 (en) 2005-04-28 2006-11-02 Ferring B.V. Use of novel compounds for ibd treatment
UY30048A1 (es) 2005-12-23 2007-07-31 Astrazeneca Ab Derivados sustituidos de la n,2-(1h-benzimidazol-1-il) acetamida, composiciones farmacéuticas conteniéndolos, procesos de preparación y aplicaciones
WO2007091950A1 (en) * 2006-02-07 2007-08-16 Astrazeneca Ab Benzimidazoles and imidazopyridines useful in the treatment of diseases or disorders associated with cannabinoid receptor 2 (cb2) such as pain
CA2645257C (en) * 2006-03-06 2011-11-01 Pfizer Inc. Sulfonyl benzimidazole derivatives
TW200745049A (en) 2006-03-23 2007-12-16 Astrazeneca Ab New crystalline forms
TW200808769A (en) 2006-04-18 2008-02-16 Astrazeneca Ab Therapeutic compounds
TW200808772A (en) * 2006-06-13 2008-02-16 Astrazeneca Ab Therapeutic compounds
ATE459352T1 (de) * 2006-07-04 2010-03-15 Janssen Pharmaceutica Nv Benzimidazol-cannabinoid-agonisten mit einer substituierten heterocyclischen gruppe
TWI433839B (zh) 2006-08-11 2014-04-11 Neomed Inst 新穎的苯并咪唑衍生物290
FR2907784B1 (fr) * 2006-10-27 2009-02-13 Sod Conseils Rech Applic Derives phenyliques et leur utilisation comme medicament
WO2009116074A2 (en) * 2008-02-13 2009-09-24 Cadila Healthcare Limited Substituted benzimidazoles as cannabinoid modulator
US20120277296A1 (en) 2009-07-23 2012-11-01 Sophie Lotersztajn Selective CB2 Receptor Agonists for Use in the Prevention or Treatment of Alcoholic Liver Disease
US20110086853A1 (en) * 2009-10-08 2011-04-14 William Brown Therapeutic Compounds
US8759535B2 (en) 2010-02-18 2014-06-24 High Point Pharmaceuticals, Llc Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use thereof
EP2536285B1 (en) 2010-02-18 2018-04-25 vTv Therapeutics LLC Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use thereof
EP3263568B1 (en) * 2011-07-18 2021-08-25 Merck Patent GmbH Benzamides
CN102977056B (zh) * 2012-11-28 2014-11-26 深圳万乐药业有限公司 N-苄氧羰基-3-氟-4-吗啉基苯胺的合成方法
WO2016089648A1 (en) 2014-12-01 2016-06-09 Vtv Therapeutics Llc Bach 1 inhibitors in combination with nrf2 activators and pharmaceutical compositions thereof
CN107531679B (zh) * 2016-03-18 2021-07-02 江苏恒瑞医药股份有限公司 芳香酰胺类衍生物、其制备方法及其在医药上的应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2945044A (en) * 1957-07-12 1960-07-12 Ciba Pharm Prod Inc Certain 1-(diethyl-aminoethyl), 5-amino, 2-benzyl or substituted benzyl, benzimidazoles
FR1481049A (fr) 1965-11-25 1967-05-19 France Ministre Des Armees Nouveaux dialkylaminoalkyl-1 p-alkoxyphényl alkyl-2 benzimidazoles 5-substitués
CA2180122A1 (en) * 1994-01-03 1995-07-13 Sui Xiong Cai 8-aza, 6-aza and 6,8-diaza-1,4-dihydroquinoxaline-2,3-diones and the usethereof as antagonists for the glycine/nmda receptor
SE0203070D0 (en) * 2002-10-16 2002-10-16 Astrazeneca Ab Novel compounds

Also Published As

Publication number Publication date
BR0208907A (pt) 2004-04-20
IS6971A (is) 2003-09-29
MY134568A (en) 2007-12-31
NO20034665L (no) 2003-12-10
BG108271A (bg) 2004-12-30
WO2002085866A1 (en) 2002-10-31
EE200300524A (et) 2004-02-16
CN1250531C (zh) 2006-04-12
US20060135554A1 (en) 2006-06-22
HUP0303825A2 (hu) 2004-03-01
US20040116465A1 (en) 2004-06-17
CZ20032833A3 (en) 2004-05-12
IL158142A0 (en) 2004-03-28
HUP0303825A3 (en) 2005-06-28
JP2004528334A (ja) 2004-09-16
PL366517A1 (en) 2005-02-07
US7030139B2 (en) 2006-04-18
SK13032003A3 (sk) 2005-01-03
ZA200307752B (en) 2005-01-03
NZ528403A (en) 2005-05-27
RU2312864C2 (ru) 2007-12-20
CN1503787A (zh) 2004-06-09
CA2444381A1 (en) 2002-10-31
AR035959A1 (es) 2004-07-28
NO20034665D0 (no) 2003-10-17
KR20040022421A (ko) 2004-03-12
RU2003129638A (ru) 2005-04-10
MXPA03009558A (es) 2004-02-12
UA76743C2 (uk) 2006-09-15
EP1390350A1 (en) 2004-02-25

Similar Documents

Publication Publication Date Title
SE0101387D0 (sv) Novel compounds
SE9900961D0 (sv) Novel compounds
ATE484508T1 (de) Furylverbindungen
SE0401342D0 (sv) Therapeutic compounds
DE60333746D1 (de) Thienylverbindungen
SE0104250D0 (sv) Heterocyclic compounds
SE0402762D0 (sv) Indazole sulphonamide derivatives
SE9802208D0 (sv) Novel compounds
SE0302573D0 (sv) Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
SE0301701D0 (sv) Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
HK1068348A1 (en) Therapeutic heterocycles as bradykinin b2 receptorantagonists
SE0203303D0 (sv) Novel Compounds
SE0203070D0 (en) Novel compounds
SE0301699D0 (sv) Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
SE0302570D0 (sv) Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
SE0203300D0 (sv) Novel Compounds
SE0300105D0 (sv) Diarylmethylidene piperdine derivatives, preparations thereof and uses thereof
SE0302572D0 (sv) Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
SE9802209D0 (sv) Novel compounds
SE0203302D0 (sv) Novel Compounds
SE0400027D0 (sv) Diarylmethyl piperazine derivatives, preparations thereof and uses thereof
SE0301445D0 (sv) Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof
SE0203301D0 (sv) Novel Compounds
SE0300104D0 (sv) Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof
SE0300103D0 (sv) Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof